Apollo Endosurgery, Inc. (“Apollo”), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced CE Mark approval for the ORBERA365 Managed Weight Loss System.
Apollo Endosurgery, Inc. (“Apollo”), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced CE Mark approval for the ORBERA365 Managed Weight Loss System.